Fructosamine and Glycated Albumin and the Risk of Cardiovascular Outcomes and Death

Abstract

The acceptance of new measures of hyperglycemia is partly dependent on establishing their association with long-term outcomes. We found that fructosamine and glycated albumin were associated with vascular outcomes and mortality and that these associations were similar to those observed for HbA1c.